can tirzepatide cause blood in stool with tirzepatide: causes and when to see a doctor Ischemic Colitis Associated With Tirzepatide

Reduce Blood Pressure Semaglutide has been shown to benefit blood pressure by reducing systolic and diastolic blood pressure in patients with type 2 diabetes

Also, briefly using antiemetic strategies during the toughest weeks can support patients in staying on therapy

Vincent du Vigneaud, Cornell, 1935

Phase 2: Market Creation at Scale Novo Nordisk didnt just innovateit scaled demand aggressively: Positioned GLP-1 as a dual-solution drug (diabetes + weight loss) Expanded into non-diabetic populations seeking weight management Invested heavily in manufacturing and global supply chains Built direct-to-consumer channels to improve access By 2025: GLP-1 drugs became the primary growth driver for the company Novo Nordisk held a dominant share in the GLP-1 market Demand surged globally, driven by rising obesity and diabetes rates The broader GLP-1 market is now expected to grow at ~14% CAGR, driven by lifestyle diseases and expanding use cases